Revance Therapeutics (RVNC) January 5 puts active as share price down 16.5%

Revance Therapeutics (NASDAQ: RVNC) 30-day option implied volatility is at 101; compared to its 52-week range of 14 to 134. Call put ratio 1 call to 2.4 puts with focus on January 5 puts as share price down 16.5%.

You May Also Be Interested In

• Paramount Weighs Tapping Musk For Equity Investment - Semafor
• The New York Times Co. (NYT) call put ratio 2.3 calls to 1 put with a focus on February 220 calls as share price down 1.9%
• Stitch Fix (SFIX) call put ratio 4.9 calls to 1 put with a focus on October 2.5 and 5 calls into quarter results